Trials / Conditions / FGFR2 Gene Fusion/Rearrangement
FGFR2 Gene Fusion/Rearrangement
3 registered clinical trials studyying FGFR2 Gene Fusion/Rearrangement — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Study of Lirafugratinib in Non-CCA Solid Tumors With FGFR2 Fusion or Rearrangement NCT07359820 | Elevar Therapeutics | Phase 2 |
| Active Not Recruiting | A Study of an FGFR2/3 Inhibitor (CGT4859) in Patients With Cholangiocarcinoma and Other Advanced Solid Tumors NCT06777316 | Cogent Biosciences, Inc. | Phase 1 / Phase 2 |
| Completed | REFOCUS: A First-in-Human Study of Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients With ICC and Other NCT04526106 | Elevar Therapeutics | Phase 1 / Phase 2 |